Device-Makers Can Help With Cancer ‘Moonshot,' AdvaMed Tells Biden
This article was originally published in The Gray Sheet
Executive Summary
Medical technology plays an important role in cancer treatment and cures via diagnostics and precision medicine, advanced imaging, radiation therapy and surgical oncology, AdvaMed told Vice President Joe Biden in a March 31 letter asking for a meeting with the National Cancer “Moonshot” Task Force.
You may also be interested in...
Industry to Biden: Count Us In On Cancer Moonshot
AdvaMed says the medtech industry needs to at the table to advise the government on investments that could lead to future cancer diagnostics and treatments.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.